WallStreetZenWallStreetZen

NASDAQ: SRPT
Sarepta Therapeutics Inc Stock Ownership - Who owns Sarepta Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Sarepta Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ryan Edward BrownEVP General Counsel2023-06-0189$123.60
$11.00kSell
Bilal ArifChief Tech Ops Officer2023-03-30307$136.66
$41.95kSell
Bilal ArifChief Tech Ops Officer2023-03-08314$153.19
$48.10kSell
Louise RodinoklapacHead of RD CSO2023-03-08912$153.19
$139.71kSell
Ian Michael EstepanChief Financial Officer2023-03-08744$153.19
$113.97kSell
Ryan Edward BrownSVP General Counsel2023-03-08635$153.19
$97.28kSell
Louise RodinoklapacHead of RD CSO2023-03-061,134$157.21
$178.28kSell
Bilal ArifChief Tech Ops Officer2023-03-06154$157.21
$24.21kSell
Ryan Edward BrownSVP General Counsel2023-03-06171$157.21
$26.88kSell
Ryan Edward BrownSVP General Counsel2023-03-061,154$157.21
$181.42kSell

1 of 3

SRPT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SRPT insiders and whales buy or sell their stock.

SRPT Shareholders

What type of owners hold Sarepta Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Black Bear Offshore Master Fund LP10.64%9,914,211$1.27BInsider
Vanguard Group Inc8.71%8,112,964$1.04BInstitution
Eastbourne Capital Management LLC6.08%5,659,211$723.81MInsider
Blackrock Inc5.67%5,282,695$675.66MInstitution
Janus Henderson Group PLC5.27%4,908,204$627.76MInstitution
Jpmorgan Chase Co3.98%3,702,944$473.61MInstitution
Avoro Capital Advisors LLC3.92%3,650,000$466.84MInstitution
Richard Barry3.36%3,129,842$400.31MInsider
Ecor1 Capital LLC3.22%2,999,453$383.63MInstitution
Rockall Emerging Markets Master Fund Ltd3.15%2,935,696$375.48MInsider

1 of 3

SRPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SRPT73.61%26.39%Net BuyingNet Selling
LEGN20.58%0.00%
TECH93.31%2.14%Net BuyingNet Buying
UTHR87.71%12.29%Net SellingNet Selling
APLS74.31%25.69%Net BuyingNet Buying
View Top Biotech Stocks

Sarepta Therapeutics Stock Ownership FAQ

Who owns Sarepta Therapeutics?

Sarepta Therapeutics (NASDAQ: SRPT) is owned by 85.56% institutional shareholders, 30.67% Sarepta Therapeutics insiders, and 0.00% retail investors. Black Bear Offshore Master Fund LP is the largest individual Sarepta Therapeutics shareholder, owning 9.91M shares representing 10.64% of the company. Black Bear Offshore Master Fund LP's Sarepta Therapeutics shares are currently valued at $1.25B.

If you're new to stock investing, here's how to buy Sarepta Therapeutics stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.